255 related articles for article (PubMed ID: 1572101)
21. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
[TBL] [Abstract][Full Text] [Related]
22. Production of interleukin-1 and tumor necrosis factor by bone marrow-derived macrophages: effect of cisplatin and lipopolysaccharide.
Suresh A; Sodhi A
Immunol Lett; 1991 Sep; 30(1):93-100. PubMed ID: 1959946
[TBL] [Abstract][Full Text] [Related]
23. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding AH; Nathan CF; Stuehr DJ
J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation.
Oswald IP; Wynn TA; Sher A; James SL
Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8676-80. PubMed ID: 1528880
[TBL] [Abstract][Full Text] [Related]
25. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.
Shnyra A; Brewington R; Alipio A; Amura C; Morrison DC
J Immunol; 1998 Apr; 160(8):3729-36. PubMed ID: 9558074
[TBL] [Abstract][Full Text] [Related]
26. Interferon-gamma enhances tumor necrosis factor-alpha production by inhibiting early phase interleukin-10 transcription.
Shakhov AN; Woerly G; Car BD; Ryffel B
Eur Cytokine Netw; 1996 Dec; 7(4):741-50. PubMed ID: 9010676
[TBL] [Abstract][Full Text] [Related]
27. Role of culture supernatant of cytotoxic/cytostatic macrophages in activation of murine resident peritoneal macrophages.
Hashimoto S; Nagaoka M; Hayashi K; Yokokura T; Mutai M
Cancer Immunol Immunother; 1989; 28(4):253-9. PubMed ID: 2495178
[TBL] [Abstract][Full Text] [Related]
28. [Effects of Phytolacca acinosa polysaccharides I on cytotoxicity of macrophages and its production of tumor necrosis factor and interleukin 1].
Zhang JP; Qian DH; Zheng QY
Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):375-7. PubMed ID: 2104493
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
30. Production of tumor necrosis factor alpha by resident and activated murine macrophages.
Tachibana K; Chen GJ; Huang DS; Scuderi P; Watson RR
J Leukoc Biol; 1992 Mar; 51(3):251-5. PubMed ID: 1541908
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory cytokine production in interferon-gamma-primed mice, challenged with lipopolysaccharide. Inhibition by SK&F 86002 and interleukin-1 beta-converting enzyme inhibitor.
Spinelle-Jaegle S; Devillier P; Doucet S; Millet S; Banissi C; Diu-Hercend A; Ruuth E
Eur Cytokine Netw; 2001; 12(2):280-9. PubMed ID: 11399517
[TBL] [Abstract][Full Text] [Related]
32. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
33. Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains.
Roach TI; Kiderlen AF; Blackwell JM
Infect Immun; 1991 Nov; 59(11):3935-44. PubMed ID: 1937752
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction.
Ozmen L; Pericin M; Hakimi J; Chizzonite RA; Wysocka M; Trinchieri G; Gately M; Garotta G
J Exp Med; 1994 Sep; 180(3):907-15. PubMed ID: 7914909
[TBL] [Abstract][Full Text] [Related]
35. Activated macrophage conditioned medium: identification of the soluble factors inducing cytotoxicity and the L-arginine dependent effector mechanism.
Amber IJ; Hibbs JB; Parker CJ; Johnson BB; Taintor RR; Vavrin Z
J Leukoc Biol; 1991 Jun; 49(6):610-20. PubMed ID: 1902865
[TBL] [Abstract][Full Text] [Related]
36. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
37. Role of calcium and calmodulin in the activation of murine peritoneal macrophages with cisplatin.
Sodhi A; Kumar R
Int J Immunopharmacol; 1994 Dec; 16(12):1003-10. PubMed ID: 7705961
[TBL] [Abstract][Full Text] [Related]
38. Increased production of interleukin-1 and tumor necrosis factor by human monocytes treated in vitro with cisplatin or other biological response modifiers.
Sodhi A; Pai K
Immunol Lett; 1992 Dec; 34(3):183-8. PubMed ID: 1487305
[TBL] [Abstract][Full Text] [Related]
39. In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway.
Biswas SK; Sodhi A
J Interferon Cytokine Res; 2002 May; 22(5):527-38. PubMed ID: 12060491
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta 1 primes macrophages for enhanced expression of the nitric oxide synthase gene for nitric oxide-dependent cytotoxicity against Entamoeba histolytica.
Lin JY; Seguin R; Keller K; Chadee K
Immunology; 1995 Jul; 85(3):400-7. PubMed ID: 7558128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
